Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein

Yuanming Zhang1, John C Rassa, Maria Elena deObaldia

  • 1Department of Microbiology and Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104, USA.

Journal of Virology
|September 13, 2003
PubMed

Insights

Mouse mammary tumor virus (MMTV) uses mouse transferrin receptor 1 for cell entry. Key mutations in its envelope protein

Area of Science:

  • Virology
  • Molecular Biology
  • Oncology

Background:

  • Mouse mammary tumor virus (MMTV) is a betaretrovirus.
  • MMTV utilizes mouse transferrin receptor 1 for cellular entry.
  • MMTV-like elements (h-MTVs) are found in human breast cancer cell lines.

Purpose of the Study:

  • To characterize the MMTV-SU protein's interaction with its receptor.
  • To identify the receptor-binding domain (RBD) and receptor-binding sequence (RBS).
  • To investigate the role of the heparin-binding domain (HBD) in MMTV infectivity.

Main Methods:

  • Sequence alignment of MMTV SU with Friend murine leukemia virus (F-MLV).
  • Site-directed mutagenesis of the HBD and RBS.
  • Infectivity assays using wild-type and mutant MMTV pseudoviruses.
  • Binding assays with soluble heparan sulfate and neutralizing antibodies.

Main Results:

  • Mutation of the HBD reduced MMTV infectivity.
  • Heparan sulfate blocked MMTV infection.
  • Alterations in the RBS of h-MTVs were observed.
  • A single amino acid substitution (Phe40 to Ser) in the MMTV RBS abolished cell binding and infectivity.
  • Neutralizing antibodies targeted the MMTV RBS region.

Conclusions:

  • The MMTV RBD, including a specific RBS and HBD, is critical for receptor interaction and infectivity.
  • The Phe40 residue in the MMTV RBS is essential for virus binding and infectivity.
  • MMTV receptor binding may involve fewer conformational changes compared to other murine retroviruses.

Related Concept Videos